HomeUSAGranata Bio Raises $15M in Series A+ Funding

Granata Bio Raises $15M in Series A+ Funding

-

Granata Bio Corporation

Granata Bio Corporation, a Boston, MA-based biopharma company, raised $15M in Series A+ funding.

The round saw participation from Gedeon Richter, CooperSurgical, Amboy Street Ventures, and other strategic investors.

The company intends to use the funds to support its efforts to progress its existing pipeline and explore new innovative assets in reproductive health.

Led by CEO Evan Sussman, Granata Bio is a biopharma company focused on women’s health and infertility. Its pipeline includes collaborations spanning multiple IVF product classes.

Granata has raised over $30M to date.

FinSMEs

15/01/2025

THE DAILY NEWSLETTER - SIGNUP